Prolonged Initial Phase Tapering Prednisolone Therapy In Nephrotic Syndrome

Authors

  • NAJM-UL- HASAN HASSAN

Keywords:

Nephrotic Syndrome, Prolonged Steroid Therapy

Abstract

Objective: To assess the prospects of maintaining a sustained remission by prolonged initial phase steroid therapy in nephrotic syndrome.

Design: Hospital based descriptive study.

Place and Duration: Department of Pediatric Medicine, Combined Military Hospital, Lahore, Pakistan. January 2002 to January 2010.

Patients and Methods: Fifty children of both genders in their very first episode of steroid sensitive nephrotic syndrome (SSNS) were selected after an informed parental consent. Prednisolone was used in a gradually tapering dose spread over 7 months with a post-treatment 12-month follow up. Albuminuria was monitored by dipstick method.

Results: Thirty five (70%) boys and 15 (30%) girls participated in the study with male to female ratio of 2.3:1. Mean age was 4.62±2.15 years. All the patients became albuminuria-free within first 4 weeks of treatment. Thirty two (64%) patients maintained remission during the study and 12-month follow-up period. Eighteen (36%) case relapsed within 6 months after completion of initial treatment. Eight (16%) of these 18 cases had multiple relapses. Cushingoid appearance and mild hypertrichosis was noted in all the 50 (100%) cases.

Conclusion: Prolonged initial phase tapering steroid therapy helps maintain a sustained and longer remission in SSNS. It should be adopted as the standard regimen.

References

Downloads

Published

27.11.2018

How to Cite

1.
Prolonged Initial Phase Tapering Prednisolone Therapy In Nephrotic Syndrome. J Fatima Jinnah Med Univ [Internet]. 2018 Nov. 27 [cited 2026 Apr. 4];6(2). Available from: https://jfjmu.com/index.php/ojs/article/view/230